Imprimis Pharmaceuticals, Inc.
(NASDAQ : IMMY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading IMMY News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.81%15.7814.2%$301.90m
SHPGShire PLC Sponsored ADR
-1.11%172.980.4%$213.79m
PRGOPerrigo Co. Plc
0.83%75.276.4%$143.86m
PRXLPAREXEL International Corporation
-0.36%86.807.9%$136.24m
MNKMallinckrodt Plc
2.12%46.3317.7%$126.60m
ALRAlere Inc.
-0.10%50.182.7%$93.63m
JAZZJazz Pharmaceuticals Plc
-0.43%158.802.2%$84.49m
UTHRUnited Therapeutics Corporation
-0.08%131.5913.9%$76.26m
ENDPEndo International Plc
1.63%11.848.9%$73.99m
PTLAPortola Pharmaceuticals, Inc.
46.75%56.138.9%$69.62m
HZNPHorizon Pharma plc
-1.22%11.737.6%$57.17m
AERIAerie Pharmaceuticals, Inc.
-0.45%54.808.9%$55.00m
ICPTIntercept Pharmaceuticals, Inc.
1.32%132.2922.1%$52.53m
MDCOMedicines Company
1.18%38.6022.3%$51.68m
CTLTCatalent Inc
-1.53%37.222.8%$40.04m

Company Profile

Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.,06XR60-E